期刊
CLINICAL PHARMACOLOGY & THERAPEUTICS
卷 90, 期 4, 页码 630-633出版社
WILEY
DOI: 10.1038/clpt.2011.162
关键词
-
资金
- Meijer Lavino Foundation for Cardiac Research, Aalst, Belgium
Coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) have undergone substantial technological advances, and revascularization is an established therapeutic option in the treatment of coronary artery disease (CAD). Here we focus on optimization of decision making in revascularization strategies, as is being addressed in recent large clinical trials and the guidelines issued by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据